Clinical Trial Detail

NCT ID NCT03206177
Title Paclitaxel/Carboplatin + Galunisertib for Patients With Carcinosarcoma of the Uterus or Ovary
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements No
Sponsors University of Oklahoma
Indications

fallopian tube cancer

uterine cancer

ovarian cancer

carcinosarcoma

Therapies

Carboplatin + Galunisertib + Paclitaxel

Age Groups: senior adult

No variant requirements are available.